Practical management of mild-to-moderate ulcerative colitis: an international expert consensus

被引:1
|
作者
D'Amico, Ferdinando [1 ]
Magro, Fernando [2 ]
Dignass, Axel [3 ]
Al Awadhi, Sameer [4 ]
Gutierrez Casbas, Ana [5 ,6 ]
Queiroz, Natalia Sousa Freitas [7 ]
Rydzewska, Grazyna [8 ]
Duk Ye, Byong [9 ]
Ran, Zhihua [10 ]
Hart, Ailsa [11 ]
Jairath, Vipul [12 ,13 ]
Fiorino, Gionata [14 ]
Peyrin-Biroulet, Laurent [15 ,16 ,17 ,18 ,19 ,20 ]
Danese, Silvio [1 ,21 ]
机构
[1] IRCCS San Raffaele Hosp, Gastroenterol & Endoscopy, Via Olgettina 60, Milan, Italy
[2] Univ Porto, Fac Med, CINTESIS RISE, Porto, Portugal
[3] Goethe Univ, Agaples Markus Hosp, Dept Med 1, Frankfurt, Germany
[4] Dubai Hlth, Rashid Hosp, Digest Dis Unit, Dubai, U Arab Emirates
[5] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Dept Gastroenterol, Madrid, Spain
[6] Hosp Gen Univ Alicante, Inst Invest Sanitaria & Biomed Alicante ISABIAL, Dept Gastroenterol, Alicante, Spain
[7] Santa Cruz Hosp, Gastroenterol Unit, Curitiba, Brazil
[8] Natl Med Inst Minist Interior & Adm, Dept Gastroenterol & Internal Med, Warsaw, Poland
[9] Univ Ulsan, Inflammatory Bowel Dis Ctr, AsanMed Ctr, Dept Gastroenterol,Coll Med, Seoul, South Korea
[10] Shanghai Univ Med & Hlth Sci, Zhou Pu Hosp, Dept Gastroenterol, Shanghai, Peoples R China
[11] St Marks Hosp, Inflammatory Bowel Dis Unit, London, England
[12] Western Univ, Dept Gastroenterol, Schulich Sch Med & Dent, London, ON, Canada
[13] Western Univ, Schulich Sch Med & Dent, Dept Med, London, ON, Canada
[14] San Camillo Forlanini Hosp, Dept Gastroenterol & Digest Endoscopy, IBD Unit, Rome, Italy
[15] Nancy Univ Hosp, Dept Gastroenterol, Vandoeuvre Les Nancy, France
[16] Univ Lorraine, Dept Gastroenterol, Inserm, NGERE, Nancy, France
[17] Nancy Univ Hosp, INFINY Inst, Dept Gastroenterol, Vandoeuvre Les Nancy, France
[18] Nancy Univ Hosp, FHU CURE, Dept Gastroenterol, Nancy, France
[19] Grp Hosp Prive Ambroise Pare Hartmann, Paris IBD Ctr, Dept Gastroenterol, Neuilly Sur Seine, France
[20] McGill Univ, Hlth Ctr, Div Gastroenterol & Hepatol, Dept Gastroenterol, Montreal, PQ, Canada
[21] Univ Vita Salute San Raffaele, Gastroenterol & Endoscopy, Milan, Italy
关键词
Ulcerative colitis; inflammatory bowel disease; mesalamine; 5-ASA; budesonide MMX; INFLAMMATORY-BOWEL-DISEASE; 5-AMINOSALICYLIC ACID THERAPY; FECAL CALPROTECTIN; CLINICAL-TRIAL; ORAL MESALAZINE; MAINTENANCE TREATMENT; CROHNS-DISEASE; FOLLOW-UP; MESALAMINE; REMISSION;
D O I
10.1080/17474124.2024.2397650
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
IntroductionAlthough there are well-defined guidelines for the management of mild-to-moderate ulcerative colitis (UC), there are still unmet needs. For this reason, we conducted an international expert consensus to standardize the management of patients with mild-to-moderate UC and provide practical guidance to clinicians.Areas coveredBased on Delphi methodology, 15 statements were approved after two rounds of voting, addressing several aspects of disease management from sequencing to treatment duration, from monitoring to optimization techniques and safety profile.Expert opinionGrowing knowledge of mild-to-moderate UC has led to the development of new ambitious outcomes such as histological remission and disease clearance. Furthermore, noninvasive tools for patient monitoring such as fecal calprotectin and intestinal ultrasound are now available. Their implementation in clinical practice will allow clinicians to tightly monitor disease activity and promptly adapt treatment, avoiding complications and disease progression and targeting better disease control.
引用
收藏
页码:421 / 430
页数:10
相关论文
共 50 条
  • [21] The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
    Cheon, Jae Hee
    Paridaens, Kristine
    Al Awadhi, Sameer
    Begun, Jakob
    Fullarton, John R.
    Louis, Edouard
    Magro, Fernando
    Marquez, Juan Ricardo
    Moschen, Alexander R.
    Narula, Neeraj
    Rydzewska, Grazyna
    Dignass, Axel U.
    Travis, Simon Pl
    INTESTINAL RESEARCH, 2022, : 161 - 167
  • [22] AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis (vol 156, pg 769, 2019)
    Singh, S.
    Feuerstein, J. D.
    Binion, D. G.
    GASTROENTEROLOGY, 2019, 157 (03) : 903 - 903
  • [23] Patient satisfaction in the management of mild-to-moderate ulcerative colitis: Results of a Delphi study among patients and physicians
    Casellas, Francesc
    Ginard, Daniel
    Riestra, Sabino
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (10) : 1172 - 1179
  • [24] Gut microbiome diversity in acute severe colitis is distinct from mild-to-moderate ulcerative colitis
    Kedia, S.
    Ghosh, T. S.
    Das, B.
    Jain, S.
    Bopanna, S.
    Makharia, G.
    Travis, S.
    Ahuja, V.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S114 - S115
  • [25] Reply to Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis
    Pedersen, Natalia
    Munkholm, Pia
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (08) : E15 - E16
  • [26] Mesalazine granules promote disease clearance in patients with mild-to-moderate ulcerative colitis
    Kruis, Wolfgang
    Meszaros, Silke
    Wehrum, Sarah
    Mueller, Ralph
    Greinwald, Roland
    Nacak, Tanju
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2023, 11 (08) : 775 - 783
  • [27] Oral 5-aminosalicylic acid therapy for mild-to-moderate ulcerative colitis
    Olmstead, Jill
    JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2010, 22 (11): : 586 - 592
  • [28] Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis
    Cross, Raymond K.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (10) : 1689 - 1701
  • [29] Effect of Extended MMX Mesalamine Therapy for Acute, Mild-to-Moderate Ulcerative Colitis
    Kamm, Michael A.
    Lichtenstein, Gary R.
    Sandborn, William J.
    Schreiber, Stefan
    Lees, Kirstin
    Barrett, Karen
    Joseph, Raymond
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (01) : 1 - 8
  • [30] Management and treatment optimization of patients with mild to moderate ulcerative colitis
    D'Amico, Ferdinando
    Fasulo, Ernesto
    Jairath, Vipul
    Paridaens, Kristine
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (03) : 277 - 290